These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 34303851)
1. Differential Expression of Hypoxia-Related Genes in Primary Brain Tumors and Correlation with Clinicopathologic Data. Bayat S; Mamivand A; Khoshnevisan A; Maghrouni A; Shabani S; Raouf MT; Yaseri M; Saffar H; Tabrizi M World Neurosurg; 2021 Oct; 154():e465-e472. PubMed ID: 34303851 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis. Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714 [TBL] [Abstract][Full Text] [Related]
3. Identification of hypoxia-induced genes in a malignant glioma cell line (U-251) by cDNA microarray analysis. Ragel BT; Couldwell WT; Gillespie DL; Jensen RL Neurosurg Rev; 2007 Jul; 30(3):181-7; discussion 187. PubMed ID: 17486380 [TBL] [Abstract][Full Text] [Related]
4. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo. Said HM; Hagemann C; Staab A; Stojic J; Kühnel S; Vince GH; Flentje M; Roosen K; Vordermark D Radiother Oncol; 2007 Jun; 83(3):398-405. PubMed ID: 17524506 [TBL] [Abstract][Full Text] [Related]
5. Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. Bar EE; Lin A; Mahairaki V; Matsui W; Eberhart CG Am J Pathol; 2010 Sep; 177(3):1491-502. PubMed ID: 20671264 [TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS. Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841 [TBL] [Abstract][Full Text] [Related]
7. Identification of potential biomarkers related to glioma survival by gene expression profile analysis. Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197 [TBL] [Abstract][Full Text] [Related]
8. The p75 neurotrophin receptor enhances HIF-dependent signaling in glioma. Tong B; Pantazopoulou V; Johansson E; Pietras A Exp Cell Res; 2018 Oct; 371(1):122-129. PubMed ID: 30092219 [TBL] [Abstract][Full Text] [Related]
9. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas. Fujiwara S; Nakagawa K; Harada H; Nagato S; Furukawa K; Teraoka M; Seno T; Oka K; Iwata S; Ohnishi T Int J Oncol; 2007 Apr; 30(4):793-802. PubMed ID: 17332917 [TBL] [Abstract][Full Text] [Related]
10. FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma. Srivastava C; Irshad K; Dikshit B; Chattopadhyay P; Sarkar C; Gupta DK; Sinha S; Chosdol K Int J Cancer; 2018 Feb; 142(4):805-812. PubMed ID: 28994107 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA‑576‑3p inhibits the migration and proangiogenic abilities of hypoxia‑treated glioma cells through hypoxia‑inducible factor‑1α. Hu Q; Liu F; Yan T; Wu M; Ye M; Shi G; Lv S; Zhu X Int J Mol Med; 2019 Jun; 43(6):2387-2397. PubMed ID: 31017266 [TBL] [Abstract][Full Text] [Related]
12. Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis. Qi C; Lei L; Hu J; Wang G; Liu J; Ou S J Mol Neurosci; 2020 Oct; 70(10):1521-1532. PubMed ID: 32642801 [TBL] [Abstract][Full Text] [Related]
13. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas. Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of hypoxia inducible factor-1alpha (HIF-1alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas. Jensen RL; Ragel BT; Whang K; Gillespie D J Neurooncol; 2006 Jul; 78(3):233-47. PubMed ID: 16612574 [TBL] [Abstract][Full Text] [Related]
16. Suppressing the malignant phenotypes of glioma cells by lentiviral delivery of small hairpin RNA targeting hypoxia-inducible factor-1α. Dong CG; Wu WK; Feng SY; Yu J; Shao JF; He GM Int J Clin Exp Pathol; 2013; 6(11):2323-32. PubMed ID: 24228093 [TBL] [Abstract][Full Text] [Related]
17. Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres. Méndez O; Zavadil J; Esencay M; Lukyanov Y; Santovasi D; Wang SC; Newcomb EW; Zagzag D Mol Cancer; 2010 Jun; 9():133. PubMed ID: 20515450 [TBL] [Abstract][Full Text] [Related]
18. Expression of hypoxia inducible factor-1alpha in tumors of patients with glioblastoma multiforme and transitional meningioma. Kaynar MY; Sanus GZ; Hnimoglu H; Kacira T; Kemerdere R; Atukeren P; Gumustas K; Canbaz B; Tanriverdi T J Clin Neurosci; 2008 Sep; 15(9):1036-42. PubMed ID: 18621534 [TBL] [Abstract][Full Text] [Related]
19. Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis. Ge X; Pan MH; Wang L; Li W; Jiang C; He J; Abouzid K; Liu LZ; Shi Z; Jiang BH Cell Death Dis; 2018 Nov; 9(11):1128. PubMed ID: 30425242 [TBL] [Abstract][Full Text] [Related]